Cargando…

6-Nitrodopamine Is the Most Potent Endogenous Positive Inotropic Agent in the Isolated Rat Heart

Background: 6-nitrodopamine released from rat isolated atria exerts positive chronotropic action, being more potent than noradrenaline, adrenaline, and dopamine. Here, we determined whether 6-nitrodopamine is released from rat isolated ventricles (RIV) and modulates heart inotropism. Methods: Catech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Britto-Júnior, José, Medeiros-Teixeira, Lincoln Rangel, Lima, Antonio Tiago, Dassow, Letícia Costa, Lopes-Martins, Rodrigo Álvaro Brandão, Campos, Rafael, Moraes, Manoel Odorico, Moraes, Maria Elisabete A., Antunes, Edson, De Nucci, Gilberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607994/ https://www.ncbi.nlm.nih.gov/pubmed/37895394 http://dx.doi.org/10.3390/life13102012

Ejemplares similares

Relaxation of thoracic aorta and pulmonary artery rings of marmosets (Callithrix spp.) by endothelium-derived 6-nitrodopamine
por: Britto-Júnior, J., et al.
Publicado: (2023)

Interaction of cellulose and nitrodopamine coated superparamagnetic iron oxide nanoparticles with alpha-lactalbumin
por: Mohammadi, Fakhrossadat, et al.
Publicado: (2020)

Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008)

Vasopressin Is No Inotrope
por: Roeleveld, Peter Paul
Publicado: (2018)

Total inotrope exposure score: an extension of the vasoactive inotrope score
por: Bangalore, H, et al.
Publicado: (2015)

Threshold of Inotropic Score and Vasoactive–Inotropic Score for Predicting Mortality in Pediatric Septic Shock
por: Kallekkattu, Dipu, et al.
Publicado: (2021)

Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: Lack of interaction with nitric oxide
por: Lintomen, Letícia, et al.
Publicado: (2008)

In-vitro examination of the positive inotropic effect of caffeine and taurine, the two most frequent active ingredients of energy drinks
por: Chaban, R., et al.
Publicado: (2017)

In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
por: Braz, Helyson Lucas Bezerra, et al.
Publicado: (2020)

Correction to: “in-vitro examination of the positive inotropic effect of caffeine and taurine, the two most frequent active ingredients of energy drinks”
por: Chaban, R., et al.
Publicado: (2019)

On inotropic effects of UTP in the human heart
por: Neumann, J., et al.
Publicado: (2019)

Current use of inotropes in circulatory shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2021)

Inotropic score and vasoactive inotropic score as predictors of outcomes in congenital diaphragmatic hernia: A single center retrospective study
por: Hari Gopal, Srirupa, et al.
Publicado: (2023)

Mechanisms of relaxant activity of BAY 41-2272 in rat tracheal smooth muscle in vitro
por: Toque, Haroldo AF, et al.
Publicado: (2009)

Positive inotropic action of insulin on piglet heart.
por: Rieker, R. P., et al.
Publicado: (1975)

New arylsparteine derivatives as positive inotropic drugs
por: Boido, Vito, et al.
Publicado: (2017)

Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis*
por: McIntosh, Amanda M., et al.
Publicado: (2017)

Peripheral Inotropes in Critically Ill Children: Is It Safe?
por: Mooli, Ravi K., et al.
Publicado: (2021)

Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications
por: Montenegro Junior, Renan Magalhães, et al.
Publicado: (2020)

A STUDY OF INOTROPIC MECHANISMS IN THE PAPILLARY MUSCLE PREPARATION
por: Abbott, B. C., et al.
Publicado: (1959)

Corticosteroids reduce inotrope requirements in hypotensive liver failure
por: Harry, R, et al.
Publicado: (2001)

Inotropes do not increase mortality in advanced heart failure
por: Guglin, Maya, et al.
Publicado: (2014)

Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015)

Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016)

Symmetrical peripheral gangrene in sepsis after treatment with inotropes
por: Jiang, Jiin-Ling, et al.
Publicado: (2017)

French multicentre survey on the use of inotropes after cardiac surgery
por: Bastien, Olivier, et al.
Publicado: (2005)

Inotropes in goal-directed therapy: Do we need 'goals'?
por: Futier, Emmanuel, et al.
Publicado: (2010)

Inotropes for Preterm Infants: 50 Years on Are We Any Wiser?
por: Garvey, Aisling A., et al.
Publicado: (2018)

Effects of Widespread Inotrope Use in Acute Heart Failure Patients
por: Kang, Jeehoon, et al.
Publicado: (2018)

Cardiac Inotropic Effect of Long-Term Administration of Oral Thymoquinone
por: Asoom, Lubna Ibrahim Al, et al.
Publicado: (2019)

Short-term treatments for acute cardiac care: inotropes and inodilators
por: Guarracino, Fabio, et al.
Publicado: (2020)

The impact of perioperative inotropes on the incidence of pancreatic leak following pancreaticoduodenectomy
por: Casey, Patrick, et al.
Publicado: (2019)

Long‐term administration of intravenous inotropes in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2021)

Vasoactive-inotropic score and pediatric septic shock mortality: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022)

The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022)

State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
por: Bloom, Jason E., et al.
Publicado: (2023)

Innovative treatment using tilapia skin as a xenograft for partial thickness burns after a gunpowder explosion
por: Lima-Junior, Edmar Maciel, et al.
Publicado: (2019)

The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
por: Gadelha, Renan Brito, et al.
Publicado: (2022)

Making the most of what you've got: Optimizing residual OXPHOS function in mitochondrial diseases
por: Moraes, Carlos T
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_t9f40m8hgt31nki3gud024d1cv